Youxin Ji
Overview
Explore the profile of Youxin Ji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
990
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhong J, Fei K, Wu L, Li B, Wang Z, Cheng Y, et al.
Signal Transduct Target Ther
. 2024 Dec;
9(1):369.
PMID: 39715755
A randomized double-blind phase 3 trial (CHOICE-01, NCT03856411) demonstrated that combining toripalimab with chemotherapy substantially improves progression-free survival (PFS) in advanced non-small cell lung cancer (NSCLC) patients without pretreatment. This...
2.
Wang Z, Wu L, Li B, Cheng Y, Li X, Wang X, et al.
Future Oncol
. 2024 Dec;
21(5):515-522.
PMID: 39628302
No abstract available.
3.
Han X, You Y, Guo X, Ji Y, Nie K
Int J Gen Med
. 2024 Dec;
17:5503-5510.
PMID: 39619133
Purpose: To investigate the efficiency and safety of afatinib in combination with bevacizumab in patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) G719X, S768I, and...
4.
Xu J, Wan R, Cai Y, Cai S, Wu L, Li B, et al.
Cancer Cell
. 2024 Sep;
42(9):1598-1613.e4.
PMID: 39255777
Stratification strategies for chemotherapy plus PD-1 inhibitors in advanced non-small-cell lung cancer (NSCLC) are critically demanded. We performed high-throughput panel-based deep next-generation sequencing and low-pass whole genome sequencing on prospectively...
5.
Zhao Z, Han X, You Y, Zhang J, Nie K, Ji Y
Int J Gen Med
. 2023 Dec;
16:5947-5953.
PMID: 38115968
Background: We study the characteristics and outcomes in lung cancer patients with COVID-19 Omicron variant infection. Methods: Hospitalized lung cancer patients with advanced-stage disease and laboratory-confirmed COVID-19 Omicron infection were...
6.
Zhang L, You Y, Liu X, Liu F, Nie K, Ji Y
Thorac Cancer
. 2023 Apr;
14(15):1355-1361.
PMID: 37016906
Background: The efficacy and safety of osimertinib combined with bevacizumab in non-small cell lung cancer (NSCLC) patients with brain metastasis harboring epidermal growth factor receptor (EGFR) mutations have not been...
7.
Wang Z, Wu L, Li B, Cheng Y, Li X, Wang X, et al.
J Clin Oncol
. 2022 Oct;
41(3):651-663.
PMID: 36206498
Purpose: The CHOICE-01 study investigated the efficacy and safety of toripalimab in combination with chemotherapy as a first-line treatment for advanced non-small-cell lung cancer (NSCLC). Patients And Methods: Patients (N...
8.
Zhang Y, Wei W, Liu Y, Ji Y, Su F, Liu C
Soft Matter
. 2022 Aug;
18(35):6572-6581.
PMID: 35959627
New questions and conjectures are raised on the crystal-crystal phase transition of isotactic polybutene-1 (iPB-1) containing nanofiller in the flow field. In this work, we investigate the phase transition from...
9.
Dong J, Luo S, Ning S, Yang G, Pan D, Ji Y, et al.
ACS Appl Mater Interfaces
. 2021 Dec;
13(50):60478-60488.
PMID: 34894671
Stretchability and multifunctional heating abilities are highly desired for wearable electromagnetic interference (EMI) shielding fabrics to tackle the growing electromagnetic pollution for special crowd, such as pregnant women. Herein, we...
10.
Zhu C, Ding J, Wang S, Qiu Q, Ji Y, Wang L
Thorac Cancer
. 2021 Oct;
12(23):3110-3120.
PMID: 34647417
Background: The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and...